Annual EBITDA
$138.32M$29.12M+26.66%
Summary
- Current Value
- As of today, RGEN annual EBITDA is $138.32M, up +26.66% on
- Historical Performance
- RGEN annual EBITDA is down -45.32% over the past 3 years, up +27.66% over the past 5 years
- All-Time High Comparison
- RGEN annual EBITDA is currently -45.32% below its historical high of $252.95M set on
- 3-Year Low Comparison
- RGEN annual EBITDA is +26.66% above its 3-year low of $109.21M reached on
- Sector Comparison
- RGEN annual EBITDA is higher than 85.31% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $138.32M | +26.7% | -45.3% | +27.7% | +7199.0% | |
| Quarterly EBITDA | $38.06M | -11.9% | -5.6% | -35.5% | +2169.5% | |
| TTM EBITDA | $172.83M | +24.3% | -12.2% | +4.9% | +10000.0% | |
| Price | $174.86 | +19.8% | +13.8% | -35.8% | +5468.8% | |
| PE Ratio | 238.33 | -95.8% | +174.2% | +83.7% | – | |
| Annual Revenue | $738.26M | +16.4% | -7.9% | +101.6% | +2261.1% | |
| Annual EPS | $0.86 | +289.5% | -73.3% | -22.3% | +1334.9% | |
| $59.58M | +163.1% | -69.6% | -26.7% | +10000.0% | ||
| Annual Net Income | $48.89M | +291.6% | -73.7% | -18.4% | +2373.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $252.95M | N/A | -45.3% |
| 5Y | $252.95M | -45.3% | |
| All | $252.95M | -45.3% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $109.21M | +26.7% | |
| 5Y | $108.36M | N/A | +27.7% |
| All | -$19.10M | +824.2% |
EBITDA History
FAQ
- What is the current annual EBITDA of RGEN?
- As of today, RGEN annual EBITDA is $138.32M
- What is 1-year change in RGEN annual EBITDA?
- RGEN annual EBITDA is up +26.66% year-over-year
- What is 3-year change in RGEN annual EBITDA?
- RGEN annual EBITDA is down -45.32% over the past 3 years
- How far is RGEN annual EBITDA from its all-time high?
- RGEN annual EBITDA is currently -45.32% below its historical high of $252.95M set on December 31, 2022
- How does RGEN annual EBITDA rank versus sector peers?
- RGEN annual EBITDA is higher than 85.31% of companies in Healthcare sector
- When is RGEN next annual earnings release?
- As of today, the next annual earnings release for RGEN has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$38.06M$4.46M-10.49%
Summary
- Current Value
- As of today, RGEN quarterly EBITDA is $38.06M, down -10.49% on
- Historical Performance
- RGEN quarterly EBITDA is down -11.86% year-over-year, down -5.58% over the past 3 years
- All-Time High Comparison
- RGEN quarterly EBITDA is currently -53.57% below its historical high of $81.98M set on
- 3-Year Low Comparison
- RGEN quarterly EBITDA is +121.62% above its 3-year low of $17.18M reached on
- Sector Comparison
- RGEN quarterly EBITDA is higher than 82.32% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $38.06M | -10.5% | -11.9% | -5.6% | -35.5% | |
| Annual EBITDA | $138.32M | – | +26.7% | -45.3% | +27.7% | |
| TTM EBITDA | $172.83M | -2.9% | +24.3% | -12.2% | +4.9% | |
| Price | $174.86 | +25.1% | +19.8% | +13.8% | -35.8% | |
| PE Ratio | 238.33 | +25.1% | -95.8% | +174.2% | +83.7% | |
| Quarterly Revenue | $204.13M | +5.1% | +11.9% | +28.3% | +25.3% | |
| Quarterly EPS | $0.09 | -39.9% | -66.4% | -74.6% | -86.2% | |
| $19.00M | +5.6% | +134.0% | -9.8% | -62.0% | ||
| Quarterly Net Income | $5.01M | -39.9% | -66.3% | -74.7% | -86.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $49.09M | N/A | -22.5% |
| 3Y | $49.09M | -22.5% | |
| 5Y | $81.98M | -53.6% | |
| All | $81.98M | -53.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $38.06M | at low | |
| 3Y | $17.18M | +121.6% | |
| 5Y | $17.18M | +121.6% | |
| All | -$10.90M | +449.2% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of RGEN?
- As of today, RGEN quarterly EBITDA is $38.06M
- What is RGEN quarterly EBITDA most recent change?
- RGEN quarterly EBITDA was down -10.49% on June 30, 2026
- What is 1-year change in RGEN quarterly EBITDA?
- RGEN quarterly EBITDA is down -11.86% year-over-year
- How far is RGEN quarterly EBITDA from its all-time high?
- RGEN quarterly EBITDA is currently -53.57% below its historical high of $81.98M set on June 30, 2022
- How does RGEN quarterly EBITDA rank versus sector peers?
- RGEN quarterly EBITDA is higher than 82.32% of companies in Healthcare sector
- When is RGEN next earnings release?
- The next earnings release for RGEN is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$172.83M$5.12M-2.88%
Summary
- Current Value
- As of today, RGEN TTM EBITDA is $172.83M, down -2.88% on
- Historical Performance
- RGEN TTM EBITDA is up +24.34% year-over-year, down -12.21% over the past 3 years
- All-Time High Comparison
- RGEN TTM EBITDA is currently -41.43% below its historical high of $295.06M set on
- 3-Year Low Comparison
- RGEN TTM EBITDA is +55.86% above its 3-year low of $110.89M reached on
- Sector Comparison
- RGEN TTM EBITDA is higher than 84.60% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $172.83M | -2.9% | +24.3% | -12.2% | +4.9% | |
| Annual EBITDA | $138.32M | – | +26.7% | -45.3% | +27.7% | |
| Quarterly EBITDA | $38.06M | -10.5% | -11.9% | -5.6% | -35.5% | |
| Price | $174.86 | +25.1% | +19.8% | +13.8% | -35.8% | |
| PE Ratio | 238.33 | +25.1% | -95.8% | +174.2% | +83.7% | |
| TTM Revenue | $785.10M | +2.9% | +16.5% | +10.3% | +54.4% | |
| TTM EPS | $0.73 | -19.2% | +393.8% | -66.3% | -58.9% | |
| $70.33M | +18.3% | +154.2% | -46.7% | -47.2% | ||
| TTM Net Income | $41.54M | -19.2% | +400.4% | -66.6% | -58.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $177.95M | -2.9% | |
| 3Y | $177.95M | -2.9% | |
| 5Y | $295.06M | -41.4% | |
| All | $295.06M | -41.4% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $170.91M | N/A | +1.1% |
| 3Y | $110.89M | +55.9% | |
| 5Y | $110.89M | +55.9% | |
| All | -$19.30M | +995.5% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of RGEN?
- As of today, RGEN TTM EBITDA is $172.83M
- What is RGEN TTM EBITDA most recent change?
- RGEN TTM EBITDA was down -2.88% on June 30, 2026
- What is 1-year change in RGEN TTM EBITDA?
- RGEN TTM EBITDA is up +24.34% year-over-year
- How far is RGEN TTM EBITDA from its all-time high?
- RGEN TTM EBITDA is currently -41.43% below its historical high of $295.06M set on September 30, 2022
- How does RGEN TTM EBITDA rank versus sector peers?
- RGEN TTM EBITDA is higher than 84.60% of companies in Healthcare sector
- When is RGEN next earnings release?
- The next earnings release for RGEN is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- RGEN Official Website www.repligen.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/730272/000119312526076528/0001193125-26-076528-index.htm
- RGEN Profile on Yahoo Finance finance.yahoo.com/quote/RGEN
- RGEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rgen